Live Quote · OTCHTSUFHealthcare · Drug Manufacturers - Specialty & Generic

Hisamitsu Pharmaceutical Co., Inc.

$29.00▲ 0.00%(+$0.00)

TickerSpark Score

67/100

▌ Solid

84

Valuation

80

Profitability

25

Growth

84

Health

60

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTSUF research report →

52-Week Range2% of range

Low

$28.94

Current

$29.00

High

$32.30

Company Overviewwww.hisamitsu.co.jp

About the company

Hisamitsu Pharmaceutical Co. , Inc. is a Japanese enterprise that develops and markets a range of pharmaceuticals, quasi-drugs, and medical devices.

CEO: Kazuhide Nakatomi
IPO: 2010
Employees: 2,759
HQ: Tosu, JP

Price Chart

-10.22% · this period

Valuation

Market Cap: $2.04B
P/E: 22.44
P/S: 2.61
P/B: 1.46
EV/EBITDA: 11.06
Div Yield: 1.99%

Profitability

Gross Margin: 58.96%
Op Margin: 10.99%
Net Margin: 11.75%
ROE: 6.99%
ROIC: 4.66%

Growth & Income

Revenue: $163.49B · 4.80%
Net Income: $19.22B · -11.68%
EPS: $269.27 · -8.90%
Op Income: $17.97B
FCF YoY: 90.55%

Performance & Tape

52W High: $32.30
52W Low: $28.94
50D MA: $29.00
200D MA: $29.00
Beta: 0.29
Avg Volume: 48

Get TickerSpark's AI analysis on HTSUF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · HTSUF